The company made its automated insulin delivery system available in Saudi Arabia, Kuwait, Qatar and the United Arab Emirates (UAE). Omnipod 5 became the world’s first available tubeless, wearable, automated insulin delivery system when it received FDA clearance in January 2022. It then became the first and only such system cleared for type 1 and type 2 diabetes in August 2024.

Now, the waterproof, discreet, wearable patch pump that communicates with a sensor to proactively correct for glucose highs and protect against lows is available for more people with diabetes. Its indications in the Middle East cover individuals aged two years and older with type 1 diabetes. The system can pair with the Abbott FreeStyle Libre 2 Plus and Dexcom G7 sensor in Saudi Arabia, Kuwait and the UAE. In Qatar, it can pair with G7.